Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.19.3
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenues:        
Total revenues $ 21,906 $ 16,946 $ 49,808 $ 44,526
Costs and operating expenses:        
Cost of product revenue 5,067 3,791 12,230 10,228
Research and development 8,711 7,917 25,000 22,464
Selling, general and administrative 7,869 7,344 24,180 22,485
Total costs and operating expenses 21,647 19,052 61,410 55,177
Income (loss) from operations 259 (2,106) (11,602) (10,651)
Interest income 480 199 929 444
Other expenses, net (403) (80) (615) (221)
Income (loss) before income taxes 336 (1,987) (11,288) (10,428)
Provision for (benefit from) income taxes (7) 1 12 (11)
Net Income (loss) $ 343 $ (1,988) $ (11,300) $ (10,417)
Net income (loss) per share, basic (usd per share) $ 0.01 $ (0.04) $ (0.20) $ (0.20)
Net income (loss) per share, diluted (usd per share) $ 0.01 $ (0.04) $ (0.20) $ (0.20)
Weighted average common stock shares used in computing net income (loss) per share, basic (shares) 58,287 53,597 55,818 51,609
Weighted average common stock shares used in computing net income (loss) per share, diluted (shares) 61,412 53,597 55,818 51,609
Product Sales [Member]        
Revenues:        
Total revenues $ 10,351 $ 8,405 $ 24,588 $ 18,291
Research and Development Revenue [Member]        
Revenues:        
Total revenues $ 11,555 $ 8,541 $ 25,220 $ 26,235